Richard W. Dyke
- Pharmacology top 10%
-
- Cancer Treatment and Pharmacology 4
- Cancer Risks and Factors 1
- Drug Transport and Resistance Mechanisms 1
-
- Lung Cancer Treatments and Mutations 2
-
- Dermatological and Skeletal Disorders 1
-
- Acute Myeloid Leukemia Research 1
-
- Infectious Diseases and Mycology 1
-
- Cardiac Arrhythmias and Treatments 1
- Co-authors
- R. L. NelsonMary A. RootRobert L. NelsonMartin SweeneyKoert GerzonGerald E. GutowskiDonald C. DeLongRobert L. Hamill
- Journals
- Cancer Treatment Reviews (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Richard W. Dyke
13 papers receiving 385 citations
Peers
Comparison fields: 5 of 71
- Pharmacology 66
- Oncology 157
- Infectious Diseases 54
- Molecular Biology 192
- Rheumatology 41
Countries citing papers authored by Richard W. Dyke
This map shows the geographic impact of Richard W. Dyke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard W. Dyke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard W. Dyke more than expected).
Fields of papers citing papers by Richard W. Dyke
This network shows the impact of papers produced by Richard W. Dyke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard W. Dyke. The network helps show where Richard W. Dyke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard W. Dyke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 64 | |
| 2 | 1980 | 84 | |
| 3 | 1979 | 9 | |
| 4 | 1979 | 19 | |
| 5 | Antitumor activity of deacetyl vinblastine amide sulfate (vindesine) in rodents and mitotic accumulation studies in culture. | 1978 | 26 |
| 6 | 1977 | 51 | |
| 7 | 1975 | 92 | |
| 8 | 1974 | 23 | |
| 9 | Initial clinical experience with vinglycinate sulfate, a molecular modification of vinblastine. | 1967 | 12 |
| 10 | 1964 | 17 | |
| 11 | 1959 | 1 | |
| 12 | 1959 | 6 | |
| 13 | 1954 | 11 |
About Richard W. Dyke
Richard W. Dyke is a scholar working on Oncology, Small Animals, Pharmacology, Dermatology and Pathology and Forensic Medicine, having authored 13 papers that have together received 415 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (2 papers), Dermatological and Skeletal Disorders (1 paper), Acute Myeloid Leukemia Research (1 paper), Infectious Diseases and Mycology (1 paper), Cancer Risks and Factors (1 paper), Drug Transport and Resistance Mechanisms (1 paper) and Cardiac Arrhythmias and Treatments (1 paper). The work is most often cited by research in Pharmacology (66 citations), Oncology (157 citations), Infectious Diseases (54 citations), Molecular Biology (192 citations) and Rheumatology (41 citations). Richard W. Dyke has collaborated with scholars based in United States and Germany. Frequent co-authors include R. L. Nelson, Mary A. Root, Robert L. Nelson, Martin Sweeney, Koert Gerzon, Gerald E. Gutowski, Donald C. DeLong, Robert L. Hamill, Cynthia G. Leichman and Steven M. Grunberg. Their work appears in journals such as Cancer Treatment Reviews, Cancer Chemotherapy and Pharmacology, JNCI Journal of the National Cancer Institute, Annals of Internal Medicine and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.